Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112434 · ClinicalTrials.gov registry record
Muscle Elastography in Spastic Cerebral Palsy
A clinical trial, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- 16
- Enrollment target
NCT03112434: Completed study, sponsored by Hospital for Special Surgery, New York.
NCT03112434 is a clinical trial that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03112434 has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
To date, clinical tests are unable to differentiate between the cause of muscle stiffness, although a manual instrumented spasticity assessment for the lower limb that utilizes surface electromyogram has recently been proposed. This study intends to use shear wave elastography to assess individual muscle stiffness parameters and the individual response to botulinum toxin injection in the elbow and wrist flexors. Collection of baseline spasticity parameters could then be used to predict the effect of botulinum toxin type A and ultimately serve as a basis for development of a treatment model for muscle spasticity in patients with spastic cerebral palsy.
Primary Outcome
Change in muscle elasticity (in kilopascal )
Interventions
- DRUG Botulinum toxin type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-12-14 |
| Est. Completion | 2020-12-30 |
What the finished NCT03112434 record still lists
NCT03112434 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Botulinum toxin type A is the first listed.
NCT03112434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03112434 about?
NCT03112434 is a clinical study titled "Muscle Elastography in Spastic Cerebral Palsy". To date, clinical tests are unable to differentiate between the cause of muscle stiffness, although a manual instrumented spasticity assessment for the lower limb that utilizes surface electromyogram has recently been proposed. This study intends to use shear wave elastography to assess individual m...
What is the current status of trial NCT03112434?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2017-12-14. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT03112434?
The interventions under investigation include: Botulinum toxin type A (DRUG).
Who is sponsoring clinical trial NCT03112434?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI